Research programme: kidney disorder therapeutics - Variant Pharmaceuticals

Drug Profile

Research programme: kidney disorder therapeutics - Variant Pharmaceuticals

Alternative Names: VAR 200; VAR 300; VAR 400

Latest Information Update: 19 Apr 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator L&F Research
  • Developer Variant Pharmaceuticals
  • Class Beta-Cyclodextrins
  • Mechanism of Action Cholesterol modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Diabetic neuropathies; Focal segmental glomerulosclerosis; Hereditary nephritis

Most Recent Events

  • 16 Apr 2018 Variant Pharmaceuticals completes Pre-IND meeting with FDA on VAR 200 for Focal segmental glomerulosclerosis (In adults)
  • 16 Apr 2018 Variant Pharmaceuticals plans to initiate phase IIa trial in Focal segmental glomerulosclerosis (In adults)
  • 23 Sep 2016 Preclinical trials in Diabetic neuropathies (Prevention) in USA (SC) before September 2016 (variant Pharmaceuticals pipeline, September 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top